BPC-157: 0.25-0.5 mg daily subcutaneous TB-500: Loading phase 2.5 mg twice weekly for weeks 1-4, then maintenance 2-3 mg weekly Duration: 6-8 weeks concurrent use Note: Administer separately
BPC 157 nie jest zatwierdzona do uytku medycznego przez FDA ani inne gwne agencje regulacyjne
These are activated by leptin and secrete -melanocyte stimulating hormone (-MSH), which acts on second-order neurons present in the paraventricular area that express melanocortin 4 receptor(MC4R)
It works systemically, not locally: Unlike BPC-157, which targets a specific injury site, TB-500 travels through the entire body and finds damaged tissue wherever it is, making it effective for diffuse or multi-site injuries
The following are some analyses of the molecular structure of AOD peptides: (1) Amino acid sequence: The amino acid sequence of an AOD peptide is AOD, which means it is composed of an aspartic acid (A) residue, a leucine (O) residue, and a phenylalanine (D) residue connected by peptide bonds